IMCR vs TM · rev $310.2M vs P/E 9.7, rev $234.60B
Immunocore Holdings Ltd (IMCR) versus Toyota Motor Corporation ADR (TM) — a side-by-side from cached financials, not a winner call.
Immunocore Holdings Ltd (IMCR) is a biotechnology company listed on NASDAQ.
Toyota Motor Corporation ADR (TM) is a auto manufacturers company listed on NYSE.
Latest reported IMCR revenue for 2024-12-31 was $310.2M. Net income was -$51.1M. Revenue was up 24.4% from 2023-12-31 to 2024-12-31. IMCR currently screens at market cap $1.45B.
Latest reported TM revenue for 2013-03-31 was $234.60B. Net income was $10.23B. Revenue was up 3.8% from 2012-03-31 to 2013-03-31. TM currently screens at market cap $211.00B and trailing P/E 9.7.
IMCR currently screens at market cap $1.45B. TM currently screens at market cap $211.00B and trailing P/E 9.7.
Not investment advice. Open the IMCR and TM stock pages for the full models.
Not investment advice.